REAL-WORLD EVIDENCE OF PREVALENCE OF CARDIOVASCULAR DISEASE AMONGST TREATED DIABETES POPULATION IN 2016

被引：0
|
作者：
Khamis, Z. J. [1 ]
Merali, T. [1 ]
机构：
[1] Drug Intelligence Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB7
引用
收藏
页码：A163 / A163
页数：1
相关论文
共 50 条
  • [1] PREVALENCE OF CARDIOVASCULAR DISEASE BY VASCULAR BED IN TYPE 2 DIABETES POPULATION IN A REAL-WORLD SETTING
    Weng, Wayne
    Kong, Sheldon
    Ganguly, Rahul
    Hersloev, Malene
    Brett, Jason
    Hobbs, Todd
    Baeres, Florian M. M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1759 - 1759
  • [2] The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real-world population with type 2 diabetes
    Weng, Wayne
    Kong, Sheldon X.
    Ganguly, Rahul
    Hersloev, Malene
    Brett, Jason
    Hobbs, Todd
    Baeres, Florian M. M.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (02)
  • [3] Prevalence of pharmacologically treated type 2 diabetes mellitus in 2012-2016 in Greece: Real-World Data
    Lalagkas, Panagiotis-Nikolaos
    Polyzois, Spyros
    Papanas, Nikolaos
    Nena, Evangelia
    Vourli, Nemi
    Kontogiorgis, Christos
    Constantinides, Theodoros
    PRIMARY CARE DIABETES, 2022, 16 (05) : 714 - 716
  • [4] Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study
    Chen, Guanmin
    Farris, Megan S.
    Cowling, Tara
    Pinto, Lionel
    Rogoza, Raina M.
    MacKinnon, Erin
    Champsi, Salimah
    Anderson, Todd J.
    CLINICAL CARDIOLOGY, 2021, 44 (11) : 1613 - 1620
  • [5] High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs
    Davis, Keith L.
    Meyers, Juliana
    Zhao, Zhenxiang
    McCollam, Patrick L.
    Murakami, Masahiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (12) : 1287 - 1304
  • [6] Association between cardiovascular disease and kidney disease in a sample of real-world diabetes patients
    Salmeri, Emiliano
    Elbert, Alicia
    Lavalle-Cobo, Augusto
    Aranguren, Florencia
    Sanabria, Hugo
    Giorgi, Mariano
    Forte, Ezequiel
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2022, 92 (02): : 165 - 173
  • [7] Use of Intravascular Lithotripsy in a Population With a High Prevalence of Renal Disease and Diabetes: Insights From Real-World Data
    Mohan, Poornima
    Hartley, Adam
    Khaldi, Hani
    Sethi, Amarjit
    Petraco, Ricardo
    Al-Lamee, Rasha
    Baker, Christopher
    Khamis, Ramzi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B169 - B169
  • [8] Incidence of cardiovascular events in the real-world population of cancer patients treated with targeted therapies
    Zaroff, Jonathan G.
    Corley, Douglas A.
    Zhao, Wei K.
    Titlevsky, Lina
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Real-world evidence of patients treated with alemtuzumab in Canada
    Smith, A.
    Hashemi, L.
    Poole, E.
    Gehchan, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 895 - 896
  • [10] Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes
    V. Sciannameo
    P. Berchialla
    A. Avogaro
    G. P. Fadini
    Cardiovascular Diabetology, 20
12345